Published in Gastroenterology on March 01, 1989
Mechanism of active renal tubular efflux of tenofovir. Antimicrob Agents Chemother (2006) 2.41
Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J (2002) 2.02
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics (2009) 1.90
Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol (2008) 1.83
Mechanisms of membrane transport of folates into cells and across epithelia. Annu Rev Nutr (2011) 1.76
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs. J Control Release (2005) 1.52
Symmetric infection of rotavirus on polarized human intestinal epithelial (Caco-2) cells. J Virol (1991) 1.49
Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol (2011) 1.48
Generation of lipid polarity in intestinal epithelial (Caco-2) cells: sphingolipid synthesis in the Golgi complex and sorting before vesicular traffic to the plasma membrane. J Cell Biol (1990) 1.43
Diabetes regulates fructose absorption through thioredoxin-interacting protein. Elife (2016) 1.39
Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro. Antimicrob Agents Chemother (2007) 1.37
Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol (1993) 1.34
Substrate upregulation of the human small intestinal peptide transporter, hPepT1. J Physiol (1998) 1.33
Integrin alpha5/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation. Mol Biol Cell (2000) 1.28
PepT1-mediated epithelial transport of dipeptides and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest (2001) 1.27
Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints. ACS Chem Biol (2012) 1.26
Acetaldehyde dissociates the PTP1B-E-cadherin-beta-catenin complex in Caco-2 cell monolayers by a phosphorylation-dependent mechanism. Biochem J (2007) 1.26
Bioactive peptides from muscle sources: meat and fish. Nutrients (2011) 1.25
Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog (2013) 1.22
Development of an in vitro model for study of non-O1 Vibrio cholerae virulence using Caco-2 cells. Infect Immun (1990) 1.20
Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun (1998) 1.19
Astrovirus increases epithelial barrier permeability independently of viral replication. J Virol (2007) 1.18
Preclinical pharmacology and pharmacokinetics of GW433908, a water-soluble prodrug of the human immunodeficiency virus protease inhibitor amprenavir. Antimicrob Agents Chemother (2004) 1.17
Pharmacophore-based discovery of ligands for drug transporters. Adv Drug Deliv Rev (2006) 1.15
Active secretion of the fluoroquinolone ciprofloxacin by human intestinal epithelial Caco-2 cell layers. Br J Pharmacol (1993) 1.14
GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PLoS One (2012) 1.13
The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A. PLoS One (2011) 1.13
Pinkbar is an epithelial-specific BAR domain protein that generates planar membrane structures. Nat Struct Mol Biol (2011) 1.12
Attachment of Giardia lamblia trophozoites to a cultured human intestinal cell line. Gut (1995) 1.11
Preliminary Characterization of the Transcriptional Response of the Porcine Intestinal Cell Line IPEC-J2 to Enterotoxigenic Escherichia coli, Escherichia coli, and E. coli Lipopolysaccharide. Comp Funct Genomics (2010) 1.11
Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br J Clin Pharmacol (1999) 1.10
Optimizing culture conditions of a porcine epithelial cell line IPEC-J2 through a histological and physiological characterization. Cytotechnology (2011) 1.10
Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria. Infect Immun (2000) 1.09
Cobicistat boosts the intestinal absorption of transport substrates, including HIV protease inhibitors and GS-7340, in vitro. Antimicrob Agents Chemother (2012) 1.08
The role of cell surface architecture of lactobacilli in host-microbe interactions in the gastrointestinal tract. Mediators Inflamm (2013) 1.07
KLF4 regulation in intestinal epithelial cell maturation. Exp Cell Res (2008) 1.06
Oral exposure to polystyrene nanoparticles affects iron absorption. Nat Nanotechnol (2012) 1.05
Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1. Am J Pathol (2008) 1.05
Bidirectional entry of poliovirus into polarized epithelial cells. J Virol (1993) 1.04
Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells. Br J Pharmacol (1996) 1.02
Human enteroids as an ex-vivo model of host-pathogen interactions in the gastrointestinal tract. Exp Biol Med (Maywood) (2014) 1.01
Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrob Agents Chemother (1992) 1.01
Infection of polarized cultures of human intestinal epithelial cells with hepatitis A virus: vectorial release of progeny virions through apical cellular membranes. J Virol (2000) 1.00
Entamoeba histolytica interactions with polarized human intestinal Caco-2 epithelial cells. Infect Immun (1994) 1.00
PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomaterials (2011) 0.99
Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells). Biochem J (1993) 0.98
Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epithelium. Med Microbiol Immunol (2005) 0.97
Transport of nanocarriers across gastrointestinal epithelial cells by a new transcellular route induced by targeting ICAM-1. J Control Release (2012) 0.97
Variability in P-glycoprotein inhibitory potency (IC₅₀) using various in vitro experimental systems: implications for universal digoxin drug-drug interaction risk assessment decision criteria. Drug Metab Dispos (2013) 0.96
Contrasting effects of ERK on tight junction integrity in differentiated and under-differentiated Caco-2 cell monolayers. Biochem J (2011) 0.96
Modulation of cellular phospholipid fatty acids and leukotriene B4 synthesis in the human intestinal cell (CaCo-2). Gut (1992) 0.96
Modeling kinetics of subcellular disposition of chemicals. Chem Rev (2009) 0.96
D-cycloserine uses an active transport mechanism in the human intestinal cell line Caco 2. Antimicrob Agents Chemother (1994) 0.95
Application of method suitability for drug permeability classification. AAPS J (2010) 0.93
An evaluation of the inhibitory effects against rotavirus infection of edible plant extracts. Virol J (2012) 0.93
Bundle-forming pilus retraction enhances enteropathogenic Escherichia coli infectivity. Mol Biol Cell (2011) 0.93
Plant science and human nutrition: challenges in assessing health-promoting properties of phytochemicals. Plant Cell (2011) 0.93
Comparative proteomic analysis of cell lines and scrapings of the human intestinal epithelium. BMC Genomics (2007) 0.93
Comparison of two in vitro systems to assess cellular effects of nanoparticles-containing aerosols. Toxicol In Vitro (2012) 0.93
Enhanced microscopic definition of Campylobacter jejuni 81-176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells. Infect Immun (2008) 0.93
Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation (2012) 0.92
Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells. Br J Pharmacol (1995) 0.92
The effect of complexation hydrogels on insulin transport in intestinal epithelial cell models. Acta Biomater (2009) 0.92
Application of activated nucleoside analogs for the treatment of drug-resistant tumors by oral delivery of nanogel-drug conjugates. J Control Release (2013) 0.91
Listeria monocytogenes uses Listeria adhesion protein (LAP) to promote bacterial transepithelial translocation and induces expression of LAP receptor Hsp60. Infect Immun (2010) 0.91
Repetitive deformation activates Src-independent FAK-dependent ERK motogenic signals in human Caco-2 intestinal epithelial cells. Am J Physiol Cell Physiol (2008) 0.91
Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci (2014) 0.91
Antioxidant effectiveness of organically and non-organically grown red oranges in cell culture systems. Eur J Nutr (2005) 0.91
Design, synthesis, and in vitro characterization of novel hybrid peptidomimetic inhibitors of STAT3 protein. Bioorg Med Chem (2010) 0.90
Synthetic small intestinal scaffolds for improved studies of intestinal differentiation. Biotechnol Bioeng (2014) 0.89
Priming and potentiation of DNA damage response by fibronectin in human colon cancer cells and tumor-derived myofibroblasts. Int J Oncol (2011) 0.89
Campylobacter jejuni translocation across intestinal epithelial cells is facilitated by ganglioside-like lipooligosaccharide structures. Infect Immun (2012) 0.89
5-Aminosalicylic acid inhibits the impaired epithelial barrier function induced by gamma interferon. Gut (1996) 0.88
High glucose concentration in isotonic media alters caco-2 cell permeability. AAPS PharmSci (2003) 0.87
Effects of oral glutamine supplementation on exercise-induced gastrointestinal permeability and tight junction protein expression. J Appl Physiol (1985) (2013) 0.87
Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges. J Pharm Pharm Sci (2014) 0.87
In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis. Antimicrob Agents Chemother (2014) 0.87
Functionalized carbon nanomaterials: exploring the interactions with Caco-2 cells for potential oral drug delivery. Int J Nanomedicine (2011) 0.87
Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors. Antimicrob Agents Chemother (1998) 0.87
Arachidonic acid but not eicosapentaenoic acid (EPA) and oleic acid activates NF-kappaB and elevates ICAM-1 expression in Caco-2 cells. Lipids (2007) 0.87
Enteral absorption of octreotide: absorption enhancement by polyoxyethylene-24-cholesterol ether. Br J Pharmacol (1993) 0.87
Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut. Infect Immun (2012) 0.86
Epithelial cell proliferation arrest induced by lactate and acetate from Lactobacillus casei and Bifidobacterium breve. PLoS One (2013) 0.86
Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2. Pediatr Nephrol (2008) 0.86
Remodeling of Tight Junctions and Enhancement of Barrier Integrity of the CACO-2 Intestinal Epithelial Cell Layer by Micronutrients. PLoS One (2015) 0.86
Granzyme B- and Fas ligand-mediated cytotoxic function induced by mitogenic CD28 stimulation of human memory CD4+ T cells. J Leukoc Biol (2012) 0.84
The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities. PeerJ (2015) 0.84
Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells. AAPS PharmSci (1999) 0.84
Effects of multispecies probiotic combination on helicobacter pylori infection in vitro. Clin Vaccine Immunol (2008) 0.84
Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions. BMC Microbiol (2015) 0.84
Exogenous sphingomyelinase causes impaired intestinal epithelial barrier function. World J Gastroenterol (2007) 0.83
Transepithelial transport of putrescine across monolayers of the human intestinal epithelial cell line, Caco-2. World J Gastroenterol (2001) 0.83
Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. Am J Physiol Gastrointest Liver Physiol (2013) 0.83
Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World J Gastroenterol (2013) 0.83
Transcytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway. PLoS One (2014) 0.83
Effect of Maillard reaction on biochemical properties of peanut 7S globulin (Ara h 1) and its interaction with a human colon cancer cell line (Caco-2). Eur J Nutr (2013) 0.83
pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins. Int J Pharm (2014) 0.82
Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrob Agents Chemother (2006) 0.82
Stability of protein pharmaceuticals. Pharm Res (1989) 2.92
VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol (2001) 1.63
Neplanocin A. A potent inhibitor of S-adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells. J Biol Chem (1984) 1.54
Are graduate programs training pharmaceutical scientists to function effectively in the new, highly integrated and globalized pharmaceutical industry? Pharm Res (1997) 1.52
Sinefungin, a potent inhibitor of virion mRNA(guanine-7-)-methyltransferase, mRNA(nucleoside-2'-)-methyltransferase, and viral multiplication. J Biol Chem (1978) 1.47
Structure determination of selenomethionyl S-adenosylhomocysteine hydrolase using data at a single wavelength. Nat Struct Biol (1998) 1.42
In vitro models for the blood-brain barrier. Toxicol In Vitro (2005) 1.41
Studies of inhibition of rat spermidine synthase and spermine synthase. Biochem J (1980) 1.38
Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide. Pharm Res (1990) 1.32
Transport of a large neutral amino acid (phenylalanine) in a human intestinal epithelial cell line: Caco-2. Biochim Biophys Acta (1990) 1.31
S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. J Med Chem (1991) 1.30
Structure and function of S-adenosylhomocysteine hydrolase. Cell Biochem Biophys (2000) 1.29
S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents. J Med Chem (1980) 1.25
Chemical pathways of peptide degradation. III. Effect of primary sequence on the pathways of deamidation of asparaginyl residues in hexapeptides. Pharm Res (1990) 1.24
Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size. J Pharm Sci (1997) 1.22
Effects of inhibitors of spermidine and spermine synthesis on polyamine concentrations and growth of transformed mouse fibroblasts. Biochem J (1981) 1.20
How structural features influence the biomembrane permeability of peptides. J Pharm Sci (1996) 1.19
Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells. Mol Pharmacol (1984) 1.15
Bovine brain microvessel endothelial cell monolayers as a model system for the blood-brain barrier. Ann N Y Acad Sci (1987) 1.13
A convenient preparation of S-adenosylhomocysteine and related compounds. J Org Chem (1976) 1.09
Effects of S-adenosylhomocysteine analogues on vaccinia viral messenger ribonucleic acid synthesis and methylation. Biochemistry (1982) 1.08
Transport of bile acids in a human intestinal epithelial cell line, Caco-2. Biochim Biophys Acta (1990) 1.07
Hydrogen bonding potential as a determinant of the in vitro and in situ blood-brain barrier permeability of peptides. Pharm Res (1994) 1.07
The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res (1990) 1.06
Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives. Antimicrob Agents Chemother (1989) 1.06
Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J Pharm Sci (1994) 1.05
In vitro systems for studying intestinal drug absorption. Med Res Rev (1995) 1.05
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 6. Structural modifications of S-adenosylmethionine. J Med Chem (1976) 1.05
Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. Biotechnol Bioeng (1995) 1.04
Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target. Antiviral Res (1992) 1.04
Chiral instability at sulfur of S-adenosylmethionine. Biochemistry (1983) 1.04
Passive diffusion of weak organic electrolytes across Caco-2 cell monolayers: uncoupling the contributions of hydrodynamic, transcellular, and paracellular barriers. J Pharm Sci (1995) 1.03
Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm Res (1997) 1.03
Characterization of the unstirred water layer in Caco-2 cell monolayers using a novel diffusion apparatus. Pharm Res (1991) 1.03
Primaquine blocks transport by inhibiting the formation of functional transport vesicles. Studies in a cell-free assay of protein transport through the Golgi apparatus. J Biol Chem (1991) 1.02
Stereopopulation control. II. Rate enhancement of intramolecular nucleophilic displacement. J Am Chem Soc (1972) 1.02
9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity. Antimicrob Agents Chemother (1987) 1.02
Mechanistic roles of neutral surfactants on concurrent polarized and passive membrane transport of a model peptide in Caco-2 cells. J Pharm Sci (1997) 1.01
Amine prodrugs which utilize hydroxy amide lactonization. II. A potential esterase-sensitive amide prodrug. Pharm Res (1991) 1.01
Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. Biochemistry (1995) 0.99
Effect of size and charge on the passive diffusion of peptides across Caco-2 cell monolayers via the paracellular pathway. Pharm Res (1997) 0.98
The activity of Golgi transport vesicles depends on the presence of the N-ethylmaleimide-sensitive factor (NSF) and a soluble NSF attachment protein (alpha SNAP) during vesicle formation. J Cell Biol (1992) 0.98
Sinefungin, a potent inhibitor or S-adenosylmethionine: protein O-methyltransferase. Biochem Biophys Res Commun (1979) 0.97
The use of surfactants to enhance the permeability of peptides through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm Res (1996) 0.97
Inhibition of Newcastle disease virion messenger RNA (guanine-7-)-methyltransferase by analogues of S-adenosylhomocysteine. Biochemistry (1977) 0.97
Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharm Res (1993) 0.97
Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. I. Basic characteristics and effects of D-glucose and insulin. Biochim Biophys Acta (1991) 0.96
Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm Res (1986) 0.95
Binding of epidermal growth factor by human colon carcinoma cell (Caco-2) monolayers. Biochem Biophys Res Commun (1989) 0.95
Determination of the affinity of drugs toward serum albumin by measurement of the quenching of the intrinsic tryptophan fluorescence of the protein. J Pharm Pharmacol (1999) 0.94
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 5. Role of the asymmetric sulfonium pole in the enzymatic binding of S-adenosyl-L-methionine. J Med Chem (1976) 0.94
Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol (1996) 0.94
The Alzheimer beta-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem J (1993) 0.92
Effects of 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine on the metabolism of S-adenosylhomocysteine in mouse L929 cells. Mol Pharmacol (1988) 0.92
Chemical modification and site-directed mutagenesis of cysteine residues in human placental S-adenosylhomocysteine hydrolase. J Biol Chem (1996) 0.92
Determination of O-methylated metabolites of cathecholamines using high-performance liquid chromatography and electrochemical detection. J Chromatogr (1978) 0.92
Chemical pathways of peptide degradation. VI. Effect of the primary sequence on the pathways of degradation of aspartyl residues in model hexapeptides. Pharm Res (1994) 0.92
4'-modified analogues of aristeromycin and neplanocin A: synthesis and inhibitory activity toward S-adenosyl-L-homocysteine hydrolase. J Med Chem (1992) 0.92
Estimating intestinal mucosal permeation of compounds using Caco-2 cell monolayers. Curr Protoc Pharmacol (2001) 0.91
Mechanism of inactivation of S-adenosylhomocysteine hydrolase by (Z)-4',5'-didehydro-5'-deoxy-5'-fluoroadenosine. J Biol Chem (1993) 0.91
Potential inhibitor of S-adenosylmethionine-dependent methyltransferases. 2. Modification of the base portion of S-adenosylhomocysteine. J Med Chem (1974) 0.91
Chemical stability of peptides in polymers. 2. Discriminating between solvent and plasticizing effects of water on peptide deamidation in poly(vinylpyrrolidone). J Pharm Sci (1999) 0.91
Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine. J Med Chem (1991) 0.90
Purification and characterization of some metabolic effects of S-neplanocylmethionine. Mol Pharmacol (1985) 0.90
Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells. Mol Pharmacol (1987) 0.90
A single mutation at lysine 426 of human placental S-adenosylhomocysteine hydrolase inactivates the enzyme. J Biol Chem (1994) 0.90
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 1. Modification of the amino acid portion of S-adenosylhomocysteine. J Med Chem (1974) 0.89
Kinetics of diketopiperazine formation using model peptides. J Pharm Sci (1998) 0.89
Potential inhibitors of S-adenosylmethionine-dependent methyltransferases. 11. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase. J Med Chem (1988) 0.89
Catechol O-methyltransferase. 10. 5-Substituted 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors. J Med Chem (1982) 0.88
The effect of verapamil on the transport of peptides across the blood-brain barrier in rats: kinetic evidence for an apically polarized efflux mechanism. J Pharmacol Exp Ther (1995) 0.88
A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells. Pharm Res (2001) 0.88
Catechol O-methyltransferase. 5. Structure-activity relationships for inhibition by flavonoids. J Med Chem (1975) 0.87
Amine prodrugs which utilize hydroxy amide lactonization. I. A potential redox-sensitive amide prodrug. Pharm Res (1991) 0.87
Intestinal absorption of alpha-methyldopa: in vitro mechanistic studies in rat small intestinal segments. J Pharmacol Exp Ther (1987) 0.87
S-Adenosylmethionine and its analogs. Structural features correlated with synthesis and methylation of mRNAs of cytoplasmic polyhedrosis virus. J Biol Chem (1980) 0.87
Overexpression, purification, and characterization of S-adenosylhomocysteine hydrolase from Leishmania donovani. Arch Biochem Biophys (2000) 0.86
Demonstration and structural comparison of receptors for insulin-like growth factor-I and -II (IGF-I and -II) in brain and blood-brain barrier. Biochem Biophys Res Commun (1987) 0.86
Chemical stability of peptides in polymers. 1. Effect of water on peptide deamidation in poly(vinyl alcohol) and poly(vinyl pyrrolidone) matrixes. J Pharm Sci (1999) 0.86
Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2. Pharm Res (1996) 0.86
Catechol O-methyltransferase. 1. Kinetics of tropolone inhibition. J Med Chem (1973) 0.85
Synthesis and conformational analysis of a coumarinic acid-based cyclic prodrug of an opioid peptide with modified sensitivity to esterase-catalyzed bioconversion. J Pept Res (2002) 0.85
Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine). J Med Chem (1998) 0.85
Mechanism of L-alpha-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm Res (1990) 0.85
Transport of a large neutral amino acid in a human intestinal epithelial cell line (Caco-2): uptake and efflux of phenylalanine. Biochim Biophys Acta (1992) 0.85
Prodrug strategies based on intramolecular cyclization reactions. J Pharm Sci (1997) 0.84
Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth. Antimicrob Agents Chemother (1989) 0.84
Purification and characterization of rat liver microsomal thiol methyltransferase. Biochim Biophys Acta (1978) 0.84
Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: possible function in insulin processing in the blood-brain barrier. J Cell Physiol (1994) 0.84
Analytical and numerical techniques for evaluation of free radical damage in cultured cells using imaging cytometry and fluorescent indicators. Methods Enzymol (1999) 0.84
A molecular model for the active site of S-adenosyl-L-homocysteine hydrolase. J Comput Aided Mol Des (1991) 0.84
The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers. Pharm Res (1997) 0.84
Orally active peptidomimetic RGD analogs that are glycoprotein IIb/IIIa antagonists. Curr Med Chem (2000) 0.83
Anticancer and antiviral effects and inactivation of S-adenosyl-L-homocysteine hydrolase with 5'-carboxaldehydes and oximes synthesized from adenosine and sugar-modified analogues. J Med Chem (1997) 0.83
Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide. Biochemistry (1994) 0.83
Photoaffinity labeling of human placental S-adenosylhomocysteine hydrolase with [2-3H]8-azido-adenosine. J Biol Chem (1995) 0.83
Blood-brain barrier: transport studies in isolated brain capillaries and in cultured brain endothelial cells. Adv Pharmacol (1991) 0.83
Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone. Pharm Res (1990) 0.83